Working Paper
23 May 2025
Firm-Level Innovation and the Role of Political Capabilities: Evidence for the Pharmaceuticals Industry
Published by: Institute of Development Studies
The global debate on balancing incentives for innovation in the pharmaceutical industry and facilitating competition for greater access to affordable medicines and vaccines has intensified in the aftermath of the Covid-19 pandemic. Drug discovery and vaccine development are expensive processes involving significant research and development (R&D) costs.
